Literature DB >> 5931269

Orbital rhabdomyosarcoma. An analysis of 62 cases.

I S Jones, A B Reese, J Kraut.   

Abstract

Entities:  

Mesh：

Year:  1966        PMID： 5931269

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  11 in total

1.  Rhabdomyosarcoma of the orbit.

Authors:  M J Hogan
Journal:  Calif Med       Date:  1973-01

2.  Orbital rhabdomyosarcoma: an electron microscopic study.

Authors:  M J Hogan; I Wood
Journal:  Trans Am Ophthalmol Soc       Date:  1972

3.  Rhabdomyosarcoma of the iris. Report of the first recorded case.

Authors:  S Woyke; R Chwirot
Journal:  Br J Ophthalmol       Date:  1972-01       Impact factor: 4.638

4.  Orbital rhabdomyosarcoma in an infant.

Authors:  G C Sood; D K Sen; R Diwan; A L Aurora
Journal:  Br J Ophthalmol       Date:  1970-03       Impact factor: 4.638

5.  Combined treatment modalities of orbital rhabdomyosarcoma in children.

Authors:  A Fois; A M Bardelli; R Frezzotti; A Acquaviva; C Bernardini; T Hadjistilianou
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

6.  The management of rhabdomyosarcoma in children and young adults.

Authors:  D M Hays
Journal:  World J Surg       Date:  1980-01       Impact factor: 3.352

7.  Primary ophthalmic rhabdomyosarcoma in 33 patients.

Authors:  C L Shields; J A Shields; S G Honavar; H Demirci
Journal:  Trans Am Ophthalmol Soc       Date:  2001

8.  Orbital masses: CT and MRI of common vascular lesions, benign tumors, and malignancies.

Authors:  Sarah N Khan; Ali R Sepahdari
Journal:  Saudi J Ophthalmol       Date:  2012-10

9.  Local therapy of rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma of children and adolescents.

Authors:  G Prindull; H G Willert; G Notter
Journal:  Eur J Pediatr       Date:  1985-07       Impact factor: 3.183

Review 10.  [Diagnostics of benign and malignant tumors of the orbit].

Authors:  Rahul A Jonas; Alexander C Rokohl; Vinodh Kakkassery; Katharina A Ponto; Philipp Lohneis; Ludwig M Heindl
Journal:  Ophthalmologe       Date:  2021-07-01       Impact factor: 1.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.